Today news
About the same in other media
Cancer drug specialist Clinigen agrees to £1.2bn takeover
Reading now: 334
The cancer drug specialist Clinigen has agreed to a £1.2bn takeover deal from a London-based investment firm, becoming the latest big British company to be taken private.
Triton Investment Management has offered to pay 883p a share for the company, whose main product is the acquired cancer medicine Proleukin.
Clinigen, which is based in Burton-on-Trent, Staffordshire, said its board had recommended the offer to shareholders, which include the New York hedge fund Elliott Management, with a 7.6%
Read more on theguardian.comAbout this in other media
French billionaire amasses 18% stake in UK telecoms giant BT, fueling takeover fears cnbc.com /3 years ago
UK regulator to look at Microsoft takeover bid for AI firm Nuance theguardian.com /3 years ago
Is BT the next British company in line for a takeover? theguardian.com /3 years ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
